Clinical Trial Update: ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis [NA]

View source ↗

Summary

The CENTERA Transcatheter Heart Valve System trial for intermediate-risk patients with symptomatic, severe calcific aortic stenosis is active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• CENTERA Transcatheter Heart Valve System

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Valve Stenosis | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-09-30